AVANOS MEDICAL INC (AVNS) Stock Analyst Ratings

NYSE:AVNS • US05350V1061

15.46 USD
+0.25 (+1.64%)
At close: Feb 20, 2026
15.6 USD
+0.14 (+0.91%)
After Hours: 2/20/2026, 8:17:53 PM
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to AVNS. The Buy consensus is the weighted average rating of the current analysts ratings.

  • AVNS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about AVNS.
  • In the previous month the buy percentage consensus was at a similar level.
  • AVNS was analyzed by 6 analysts. More opinions would make the average more meaningful.
AVNS Historical Analyst RatingsAVNS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8
AVNS Current Analyst RatingAVNS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2024-05-07 JMP Securities Reiterate Market Perform
2023-07-25 Keybanc Downgrade Overweight -> Sector Weight
2023-06-21 Stifel Reiterate Hold -> Hold
2023-05-22 CL King Initiate Buy
2023-05-04 Morgan Stanley Maintains Underweight
2023-02-22 Morgan Stanley Maintains Underweight
2023-01-06 Morgan Stanley Maintains Underweight
2022-11-03 Keybanc Maintains Overweight
2022-10-11 Morgan Stanley Maintains Underweight
2022-08-10 Keybanc Maintains Overweight
2022-07-18 Stifel Maintains Hold
2022-07-15 Morgan Stanley Maintains Underweight
2022-05-05 Morgan Stanley Maintains Underweight
2022-02-24 Keybanc Maintains Overweight
2022-01-07 Morgan Stanley Maintains Underweight
2021-08-04 Keybanc Maintains Overweight
2021-08-04 Stephens & Co. Downgrade Overweight -> Equal-Weight
2021-08-04 Morgan Stanley Maintains Underweight

AVANOS MEDICAL INC / AVNS FAQ

How do analysts rate AVANOS MEDICAL INC (AVNS)?

The consensus rating for AVANOS MEDICAL INC (AVNS) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.